Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines
- 22 June 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 358 (1), 164-169
- https://doi.org/10.1016/j.bbrc.2007.04.089
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Integrative Genomic Analysis Identifies NDRG2 as a Candidate Tumor Suppressor Gene Frequently Inactivated in Clinically Aggressive MeningiomaCancer Research, 2005
- NDRG2: a novel Alzheimer's disease associated proteinNeurobiology of Disease, 2004
- Akt Mediates Insulin-stimulated Phosphorylation of Ndrg2Published by Elsevier BV ,2004
- Expression and regulation of NDRG2 (N‐myc downstream regulated gene 2) during the differentiation of dendritic cellsFEBS Letters, 2003
- N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferationInternational Journal of Cancer, 2003
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- Characterization of Rat NDRG2 (N-Myc Downstream Regulated Gene 2), a Novel Early Mineralocorticoid-specific Induced GenePublished by Elsevier BV ,2002
- Characterization of the Human NDRG Gene Family: A Newly Identified Member, NDRG4, Is Specifically Expressed in Brain and HeartGenomics, 2001
- Loss of heterozygosity (LOH) atp53 is correlated with LOH atBRCA1 andBRCA2 in various human malignant tumorsInternational Journal of Cancer, 2000
- DNA methylation inhibits transcription indirectly via a methyl-CpG binding proteinCell, 1991